Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review
- PMID: 23300226
- PMCID: PMC5813813
- DOI: 10.1177/0194599812471817
Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review
Abstract
Objective: The goal of this systematic review was to examine the evidence for the use of the neuromodulating agents, amitriptyline, gabapentin, pregabalin, and baclofen, in the management of chronic, idiopathic cough patients.
Data sources: Online databases, including PubMed, Embase, Cochrane Review, and Web of Science, and publications cited in bibliographies were used.
Review methods: Literature was searched by the 2 authors with a priori criteria for study selection.
Results: Eight relevant articles were identified, including 2 randomized controlled trials, 2 prospective cohort or case-series designs with consecutive patients, 1 retrospective case series of consecutive patients, 1 retrospective case series whose consecutive status was not known, and 2 case reports of 6 and 2 patients, respectively. Improvements in cough-specific quality of life were noted in the randomized controlled trials. Cough severity was reduced in studies that measured this outcome measure. In the remaining studies, cough symptoms were less after neuromodulator treatment.
Conclusion: Benefit from neuromodulator treatment with amitriptyline, gabapentin, pregabalin, and baclofen in chronic, idiopathic cough patients was demonstrated. Further investigations using objective and subjective outcome measures are needed as well as studies exploring optimal dose, length of treatment, and relapse rates posttreatment.
Conflict of interest statement
Similar articles
-
Are neuromodulating medications effective for the treatment of chronic neurogenic cough?Laryngoscope. 2017 May;127(5):1007-1008. doi: 10.1002/lary.26393. Epub 2016 Nov 15. Laryngoscope. 2017. PMID: 27861928 Free PMC article. Review. No abstract available.
-
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2. Cochrane Database Syst Rev. 2017. PMID: 28779491 Free PMC article. Review.
-
Gabapentin in chronic cough.Pulm Pharmacol Ther. 2015 Dec;35:145-8. doi: 10.1016/j.pupt.2015.06.007. Epub 2015 Jul 2. Pulm Pharmacol Ther. 2015. PMID: 26141016 Review.
-
Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial.Lancet. 2012 Nov 3;380(9853):1583-9. doi: 10.1016/S0140-6736(12)60776-4. Epub 2012 Aug 28. Lancet. 2012. PMID: 22951084 Clinical Trial.
-
Management of recurrent laryngeal sensory neuropathic symptoms.Ann Otol Rhinol Laryngol. 2010 Mar;119(3):188-91. doi: 10.1177/000348941011900307. Ann Otol Rhinol Laryngol. 2010. PMID: 20392032
Cited by
-
Successful use of guanfacine in a patient with chronic refractory cough: A case report.Respir Med Case Rep. 2017 Oct 4;22:268-270. doi: 10.1016/j.rmcr.2017.10.001. eCollection 2017. Respir Med Case Rep. 2017. PMID: 29201635 Free PMC article.
-
Clinical Practice Guidelines for Diagnosis and Management of Cough-Chinese Thoracic Society (CTS) Asthma Consortium.J Thorac Dis. 2018 Nov;10(11):6314-6351. doi: 10.21037/jtd.2018.09.153. J Thorac Dis. 2018. PMID: 30622806 Free PMC article. Review. No abstract available.
-
Examining the Influence of Chemosensation on Laryngeal Health and Disorders.J Voice. 2023 Mar;37(2):234-244. doi: 10.1016/j.jvoice.2020.12.029. Epub 2021 Jan 15. J Voice. 2023. PMID: 33455853 Free PMC article. Review.
-
Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux Evaluation.Clin Gastroenterol Hepatol. 2022 Apr;20(4):776-786.e1. doi: 10.1016/j.cgh.2021.05.025. Epub 2021 May 20. Clin Gastroenterol Hepatol. 2022. PMID: 34022451 Free PMC article.
-
ATP, an attractive target for the treatment of refractory chronic cough.Purinergic Signal. 2022 Sep;18(3):289-305. doi: 10.1007/s11302-022-09877-z. Epub 2022 Jun 21. Purinergic Signal. 2022. PMID: 35727480 Free PMC article. Review.
References
-
- Barbee RA, Halonen M, Kalktenborn WT, Burrows B. A longitudinal study of respiratory symptoms in a community population sample. Chest. 1991;99:20–26. - PubMed
-
- Centers for Disease Control and Prevention. National Ambulatory Medical Care Survey: 2009 summary tables. www.cdc.gov/nchs/data/ahcd/namcs_summary/2009_namcs_web_tables.pdf. Accessed September 5, 2012.
-
- Consumer Healthcare Products Association. OTC sales by category—2008–2011. http://chpa-info.org/pressroom/Sales_Category.aspx. Accessed September 5, 2012.
-
- Brignall K, Jayaraman B, Birring SS. Quality of life and psychosocial aspects of cough. Lung. 2008;371:1364–1374. - PubMed
-
- Raj AA, Birring SS. Clinical assessment of chronic cough severity. Pulm Pharmacol Ther. 2007;20:334–337. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical